Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Total 13F shares
-
6,153,233
-
Share change
-
+566,231
-
Total reported value
-
$33,836,990
-
Put/Call ratio
-
96%
-
Price per share
-
$5.50
-
Number of holders
-
59
-
Value change
-
+$3,324,143
-
Number of buys
-
32
-
Number of sells
-
17
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q1 2023
As of 31 Mar 2023,
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,153,233 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Laurion Capital Management LP, Janney Montgomery Scott LLC, GREAT POINT PARTNERS LLC, Retirement Planning Co of New England, Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC, and Mystic Asset Management, Inc..
This page lists
59
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.